safety of rituximab in rheumatoid arthritis
Clicks: 144
ID: 256038
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
144 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #47 of 51 articles by views in advances in civil engineering
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infectious events (SIEs), malignancies and cardiovascular disease (1). Moreover, a long administration of drugs is required in this chronic disease, a condition that is responsible of a greater risk of side effects. As an example, there is an almost 2-fold greater risk on a SIE in patients with RA than in general population (2). Furthermore bacterial infection, one of the leading cause of morbidity and mortality in RA patients (3), is not an uncommon side effect of therapy. In addition, the use of corticosteroids, even at low doses (10 mg per day or less), utilized in approximately 65% of patients in randomized clinical trials is an important contributory factor to the increased prevalence of SIEs among RA patients (2, 4)...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (127 words).
Try re-searching for a better abstract.
| Reference Key |
atzeni2011reumatismosafety
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;F. Atzeni;P. Sarzi-Puttini;M. Covelli;P. Macchioni |
| Journal | advances in civil engineering |
| Year | 2011 |
| DOI |
10.4081/reumatismo.2010.101
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.